Creatine Linked to Lower Risk of Death and Jenerise Featured in Review

A new large-scale study led by Sergej Ostojic, PhD, and covered this week by NutraIngredients-USA, has linked creatine intake with reduced all-cause mortality, offering powerful new validation for what many in the scientific community have long believed: creatine is more than a performance supplement, it’s a foundational longevity molecule.

At Jenerise, we’re proud to be featured in this pivotal moment as the conversation around creatine evolves from gym floors to the frontlines of proactive healthcare. The study, which included data from over 15,000 U.S. adults, showed that those with higher dietary creatine intake had a lower risk of death from any cause.

“This is the kind of research that helps shift creatine into the healthspan mainstream,” says Steve Jennings, Jenerise co-founder and long-time creatine pioneer. “We’ve always believed creatine belongs in everyday routines, not just performance stacks, and the data keeps stacking up in its favour.”

As a company preparing to unlock liquid-stable creatine for mass-market beverages and functional foods, we see this study as a call to action to continue making creatine more accessible, more intuitive, and more integrated into the way we live and grow older.

For questions or PR, media and podcast inquiries, please email rachael@jenerise.com